Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 1/2/2025Hutchmed Announces $608M Non-core Chinese Unit Stake Sale
  • 1/2/2025Roche and Innovent Enter Global License Deal for Novel DLL3 ADC 
  • 12/30/2024Reforgene Secures Major Financing to Advance Gene-Editing Therapies
  • 12/30/2024CARsgen Reports Positive Topline Results from China GC/GEJ Pivotal Pha...
  • 12/30/2024Duality Announces B7H4 ADC Milestone and License Exercise by BeiGene
  • 12/30/2024Solasia Struggles to Finalize China Deal, Lowers 2024 Financial Guidan...
  • 12/30/2024 India Deepens Ties with Chinese Biotech: Cipla and Mankind Lead the W...
  • 12/29/2024CSRC Approves Ascentage Pharma's U.S. IPO Filing
  • 12/29/2024Hong Kong Accepts IPO Application from GenFleet Therapeutics
  • 12/29/2024IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for AD...
  • 12/27/2024AusperBio Secures $73M in Series B Financing to Advance Functional Cur...
  • 12/25/2024Huaota Biopharma Secures CNY 200M in Financing to Drive R&D
  • 12/25/2024Hechuang Biotech Secures Series A Funding to Advance CGT Research
  • 12/25/2024Eli Radiopharma Raises Funds to Accelerate Radiopharma Innovations
  • 12/24/2024Sanofi Reaffirms Commitment to China's Growing Biopharmaceutical Secto...
  • 12/24/2024Fosun Pharma's Parent Company Pledges 27% of Its A-shares
  • 12/24/2024WuXi Biologics to Divest Advanced Therapies Unit Amid U.S. Restriction...
  • 12/24/2024 Ascentage Pharma Secures Chinese Regulatory Approval for U.S. Nasdaq ...
  • 12/23/2024RAPT Thera and Jemincare Enter License Deal for Novel Long-Acting an...
  • 12/23/2024CORXEL Acquires ex-Greater China Rights to an Oral Small Molecule GLP...
  • 12/23/2024Roch Secures Chinese Approval of Lunsumio (Mosunetuzumab) for r/r Fol...
  • 12/23/2024MSD Finalizes Exclusive Global License Deal for Anti-PD-1 LM-299
  • 12/23/2024Sanofi Acquires Rights to Cytokinetics's Aficamten in Greater China
  • 12/23/2024Shionogi Acquires Pingan's Stake in AI-Focused JVs
  • 12/19/2024BMS China Regains Rights to GPC3 Targeted Drug ABZ-706 in Greater Chin...
  • 12/19/2024Palleon and Henlius Collaborate to Advance Glycan Editing for Autoimmu...
  • 12/19/2024Aadi Partners with WuXi Bio and DAC for Next-Gen ADCs, Secures $100M P...
  • 12/18/2024BMS and Fangzhou Forge Strategic Alliance to Advance Digital Healthcar...
  • 12/18/2024IFC Proposes $200M Loan to 3SBio to Improve Access in China and Develo...
  • 12/18/2024Merck and Hansoh Enter into Global License Deal for Investigational Or...
  • Page:11/23 Total number of articles:663: [First][<<] [9] [10] [11] [12] [13] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group